This article was originally published in the American Bar Association’s publication Health eSource, vol. 34, no.2, April 13, 2020. Proposed Opioid Settlement: Purdue Pharma In September 2019, Purdue Pharma (Purdue) announced its agreement in principle on a framework for a “landmark” opioid litigation settlement worth,
Medicare Advantage Organizations Generally, Medicare Advantage Organizations (MAOs) maintain provider networks and either limit an enrollee’s ability to obtain Medicare-covered services from out-of-network providers or charge enrollees more when they receive services from out-of-network providers. On March 10, 2020, CMS released guidance for MAOs (as
In response to the COVID-19 pandemic, hospitals face unique challenges under EMTALA and HIPAA regulations. This guidance outlines essential requirements for medical screening examinations, patient transfers, and the limited waiver of HIPAA sanctions. Discover how hospitals can adapt their protocols to ensure compliance while prioritizing